Page last updated: 2024-09-05

cannabidiol-3-monomethyl ether and cannabidiol dimethyl ether

cannabidiol-3-monomethyl ether has been researched along with cannabidiol dimethyl ether in 3 studies

Compound Research Comparison

Studies
(cannabidiol-3-monomethyl ether)
Trials
(cannabidiol-3-monomethyl ether)
Recent Studies (post-2010)
(cannabidiol-3-monomethyl ether)
Studies
(cannabidiol dimethyl ether)
Trials
(cannabidiol dimethyl ether)
Recent Studies (post-2010) (cannabidiol dimethyl ether)
501603

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Appendino, G; Giana, A; Gibbons, S; Grassi, G; Pagani, A; Rahman, MM; Smith, E; Stavri, M1
Gohda, H; Narimatsu, S; Yamamoto, I; Yoshimura, H1
Takeda, S; Usami, N; Watanabe, K; Yamamoto, I1

Other Studies

3 other study(ies) available for cannabidiol-3-monomethyl ether and cannabidiol dimethyl ether

ArticleYear
Antibacterial cannabinoids from Cannabis sativa: a structure-activity study.
    Journal of natural products, 2008, Volume: 71, Issue:8

    Topics: Acetylation; Anti-Bacterial Agents; Cannabinoids; Cannabis; Magnetic Resonance Spectroscopy; Methicillin Resistance; Methylation; Microbial Sensitivity Tests; Spectrophotometry, Infrared; Spectrophotometry, Ultraviolet; Staphylococcus aureus; Structure-Activity Relationship

2008
In vivo and in vitro metabolism of cannabidiol monomethyl ether and cannabidiol dimethyl ether in the guinea pig: on the formation mechanism of cannabielsoin-type metabolite from cannabidiol.
    Chemical & pharmaceutical bulletin, 1990, Volume: 38, Issue:6

    Topics: Animals; Biotransformation; Cannabidiol; Guinea Pigs; In Vitro Techniques; Male

1990
Cannabidiol-2',6'-dimethyl ether, a cannabidiol derivative, is a highly potent and selective 15-lipoxygenase inhibitor.
    Drug metabolism and disposition: the biological fate of chemicals, 2009, Volume: 37, Issue:8

    Topics: Animals; Cannabidiol; Dose-Response Relationship, Drug; Humans; Lipoxygenase Inhibitors; Masoprocol; Methylation; Molecular Structure; Structure-Activity Relationship

2009